The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination

Monique Marylin Alves de Almeida1, Francesca Pieropan2, Larissa de Mattos Oliveira3

  • 1Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Brazil; School of Pharmacy and Biomedical Sciences, University of Portsmouth, United Kingdom.

Insights

Agathisflavone, a flavonoid, promotes myelin repair in the central nervous system by modulating microglia activation. This effect is mediated through estrogen receptor alpha, suggesting a new therapeutic avenue for demyelinating diseases like multiple sclerosis.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Myelin loss is a key feature of multiple sclerosis (MS) and other neurodegenerative diseases.
  • Microglia, the immune cells of the central nervous system (CNS), play a critical role in neuropathologies, exhibiting both pro- and anti-inflammatory functions.
  • Understanding microglial modulation is crucial for developing therapeutic strategies for CNS repair.

Purpose of the Study:

  • To investigate the effects of the flavonoid agathisflavone on microglial activation and remyelination.
  • To explore the potential role of estrogen receptor alpha (ERα) in mediating agathisflavone's effects on CNS repair.

Main Methods:

  • Utilized a cerebellar slice model of demyelination induced by lysolecithin.
  • Administered agathisflavone and assessed its impact on remyelination and microglial morphology/cytokine profiles.
  • Investigated the role of ERα by blocking its activity and observing the effects on agathisflavone's actions.

Main Results:

  • Agathisflavone significantly enhanced remyelination in the demyelinated cerebellar slices.
  • Agathisflavone altered microglial activation states, as evidenced by changes in morphology and cytokine production.
  • The beneficial effects of agathisflavone on remyelination and microglial activation were attenuated by blockade of estrogen receptor alpha.

Conclusions:

  • Agathisflavone is a novel compound that promotes remyelination and modulates microglial activation.
  • The mechanism of action for agathisflavone appears to involve estrogen receptor alpha signaling.
  • These findings suggest agathisflavone as a potential therapeutic agent for enhancing CNS repair in demyelinating diseases.